BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37543674)

  • 61. Construction and validation of a bladder cancer risk model based on autophagy-related genes.
    Shen C; Yan Y; Yang S; Wang Z; Wu Z; Li Z; Zhang Z; Lin Y; Li P; Hu H
    Funct Integr Genomics; 2023 Jan; 23(1):46. PubMed ID: 36689018
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
    Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
    Front Genet; 2022; 13():919389. PubMed ID: 35783281
    [No Abstract]   [Full Text] [Related]  

  • 63. A Comprehensive Pan-Cancer Analysis Reveals Cyclin-Dependent Kinase Inhibitor 2A Gene as a Potential Diagnostic and Prognostic Biomarker in Colon Adenocarcinoma.
    Salem A; Ahmed S; Khalfallah M; Hamadan N; ElShikh W; Alfaki M
    Cureus; 2024 May; 16(5):e60586. PubMed ID: 38894777
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A Comprehensive Prognostic Model for Colon Adenocarcinoma Depending on Nuclear-Mitochondrial-Related Genes.
    Lv L; Huang Y; Li Q; Wu Y; Zheng L
    Technol Cancer Res Treat; 2024; 23():15330338241258570. PubMed ID: 38832431
    [No Abstract]   [Full Text] [Related]  

  • 65. Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma.
    Miao YD; Kou ZY; Wang JT; Mi DH
    World J Clin Cases; 2021 Oct; 9(29):8671-8693. PubMed ID: 34734046
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Establishment and Validation of a Novel Risk Score for Hepatocellular Carcinoma Based on Bile Acid and Bile Salt Metabolism-Related Genes.
    Shi Q; Yuan X; Xue C; Gu X; Li L
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239939
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A pairwise immune gene model for predicting overall survival and stratifying subtypes of colon adenocarcinoma.
    Jiang Z; Xu J; Zhang S; Lan H; Bao Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10813-10829. PubMed ID: 37316691
    [TBL] [Abstract][Full Text] [Related]  

  • 68. MiRNA-based model for predicting the TMB level in colon adenocarcinoma based on a LASSO logistic regression method.
    Li Z; Jiang L; Zhao R; Huang J; Yang W; Wen Z; Zhang B; Du G
    Medicine (Baltimore); 2021 May; 100(21):e26068. PubMed ID: 34032736
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Development and validation of polyamines metabolism-associated gene signatures to predict prognosis and immunotherapy response in lung adenocarcinoma.
    Wang N; Chai M; Zhu L; Liu J; Yu C; Huang X
    Front Immunol; 2023; 14():1070953. PubMed ID: 37334367
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Action of m6A-related gene signatures on the prognosis and immune microenvironment of colonic adenocarcinoma.
    Shugao H; Yinhang W; Jing Z; Zhanbo Q; Miao D
    Heliyon; 2024 Jun; 10(11):e31441. PubMed ID: 38845921
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Identification prognosis-associated immune genes in colon adenocarcinoma.
    Miao Y; Wang J; Ma X; Yang Y; Mi D
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140821
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Construction of a five-gene prognostic model based on immune-related genes for the prediction of survival in pancreatic cancer.
    Liu B; Fu T; He P; Du C; Xu K
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34143198
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Identification and validation of a prognostic risk-scoring model based on sphingolipid metabolism-associated cluster in colon adenocarcinoma.
    Yuan Q; Zhang W; Shang W
    Front Endocrinol (Lausanne); 2022; 13():1045167. PubMed ID: 36518255
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The noncoding RNAs regulating pyroptosis in colon adenocarcinoma were derived from the construction of a ceRNA network and used to develop a prognostic model.
    Chen Y; Tian Z; Hou H; Gai W
    BMC Med Genomics; 2022 Sep; 15(1):201. PubMed ID: 36127676
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A bioinformatics approach to identify a disulfidptosis-related gene signature for prognostic implication in colon adenocarcinoma.
    Hu G; Yao H; Wei Z; Li L; Yu Z; Li J; Luo X; Guo Z
    Sci Rep; 2023 Jul; 13(1):12403. PubMed ID: 37524774
    [TBL] [Abstract][Full Text] [Related]  

  • 76. m6A-related lncRNA-based immune infiltration characteristic analysis and prognostic model for colonic adenocarcinoma.
    Wang HL; Ye ZM; He ZY; Huang L; Liu ZH
    Hereditas; 2023 Feb; 160(1):6. PubMed ID: 36755298
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mining novel cell glycolysis related gene markers that can predict the survival of colon adenocarcinoma patients.
    Chen S; Cao G; Wu W; Lu Y; He X; Yang L; Chen K; Chen B; Xiong M
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32744303
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Identification and validation of novel prognostic fatty acid metabolic gene signatures in colon adenocarcinoma through systematic approaches.
    Zhang H; Cheng W; Zhao H; Chen W; Zhang Q; Yu QQ
    Oncol Res; 2023; 32(2):297-308. PubMed ID: 38186579
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A neutrophil extracellular traps-related classification predicts prognosis and response to immunotherapy in colon cancer.
    Feng C; Li Y; Tai Y; Zhang W; Wang H; Lian S; Jin-Si-Han EE; Liu Y; Li X; Chen Q; He M; Lu Z
    Sci Rep; 2023 Nov; 13(1):19297. PubMed ID: 37935721
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comprehensive Analysis of the Expression, Prognostic Value, and Immune Infiltration Activities of GABRD in Colon Adenocarcinoma.
    Huang F; Wang Z; Zhu L; Lin C; Wang JX
    Mediators Inflamm; 2023; 2023():8709458. PubMed ID: 37181811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.